Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients


Authors: 
Funnell S. G. P., Dowling W. E., Muñoz-Fontela C., Gsell P.-S., Ingber D. E., Hamilton G. A., Delang L., Rocha-Pereira J., Kaptein S., Dallmeier K. H., Neyts J., Rosenke K., de Wit E., Feldmann H., Maisonnasse P., Le Grand R., Frieman M. B., Coleman C. M.
Date of publication: 
Tuesday, 1 December, 2020
Volume: 
11
Issue: 
1
Pages: 
null
EVAg connections: 
Research funded by EVAg
Published by EVAg partner